FDA Approves Truqap
On November 16, 2023, the FDA approved capivasertib (Truqap™, AstraZeneca Pharmaceuticals) in combination with fulvestrant (Faslodex®) and a companion diagnostic...
Read More PAST ARTICLES
SEARCH OUR SITE
for past articles or specific information.